105 related articles for article (PubMed ID: 28326835)
1. Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.
Jia ZF; Wu YH; Cao DH; Cao XY; Jiang J; Zhou BS
Future Oncol; 2017 May; 13(11):979-989. PubMed ID: 28326835
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.
Wang Q; Liu H; Xiong H; Liu Z; Wang LE; Qian J; Muddasani R; Lu V; Tan D; Ajani JA; Wei Q
Mol Carcinog; 2015 Jun; 54(6):449-58. PubMed ID: 24302553
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
Lung; 2016 Jun; 194(3):393-400. PubMed ID: 27130457
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
[TBL] [Abstract][Full Text] [Related]
7. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand.
Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925
[TBL] [Abstract][Full Text] [Related]
8. Association of the miR-146a rs2910164 polymorphism with gastric cancer susceptibility and prognosis.
Jiang J; Jia ZF; Cao DH; Wu YH; Sun ZW; Cao XY
Future Oncol; 2016 Oct; 12(19):2215-26. PubMed ID: 27267319
[TBL] [Abstract][Full Text] [Related]
9. Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis.
Hassan M; Nasr SM; Elzallat M
Virus Res; 2022 Apr; 312():198714. PubMed ID: 35181408
[TBL] [Abstract][Full Text] [Related]
10. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
[TBL] [Abstract][Full Text] [Related]
11. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.
Zhang X; Hua R; Wang X; Huang M; Gan L; Wu Z; Zhang J; Wang H; Cheng Y; Li J; Guo W
Oncotarget; 2016 Mar; 7(9):9815-31. PubMed ID: 26769843
[TBL] [Abstract][Full Text] [Related]
12. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
[TBL] [Abstract][Full Text] [Related]
13. CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer.
Lee HH; Seo KJ; An CH; Kim JS; Jeon HM
J Surg Oncol; 2012 Dec; 106(8):999-1004. PubMed ID: 22674531
[TBL] [Abstract][Full Text] [Related]
14. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
16. Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond.
Soleimani A; Dadjoo P; Avan A; Soleimanpour S; Rajabian M; Ferns G; Ryzhikov M; Khazaei M; Hassanian SM
Life Sci; 2022 Mar; 293():120050. PubMed ID: 35026215
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
Huang X; Sheng Y; Guan M
Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer.
Wang C; Jia Z; Cao D; You L; Jin M; Wu X; Wen S; Cao X; Jiang J
PLoS One; 2015; 10(8):e0134059. PubMed ID: 26262893
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the stem cell marker gene
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
BMJ Open; 2017 Aug; 7(8):e016913. PubMed ID: 28827262
[TBL] [Abstract][Full Text] [Related]
20. The relationship of CD133, histone deacetylase 1 and thrombospondin-1 in gastric cancer.
Eto S; Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nakao T; Nishi M; Takasu C; Sato H; Kurita N
Anticancer Res; 2015 Apr; 35(4):2071-6. PubMed ID: 25862862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
